• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对血管平滑肌细胞的高效病毒载体的研发。

Development of efficient viral vectors selective for vascular smooth muscle cells.

作者信息

Work Lorraine M, Nicklin Stuart A, Brain Nick J R, Dishart Kate L, Von Seggern Dan J, Hallek Michael, Büning Hildegard, Baker Andrew H

机构信息

Division of Cardiovascular & Medical Sciences, Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G11 6NT, UK.

出版信息

Mol Ther. 2004 Feb;9(2):198-208. doi: 10.1016/j.ymthe.2003.11.006.

DOI:10.1016/j.ymthe.2003.11.006
PMID:14759804
Abstract

The vascular smooth muscle cell (SMC) is integral to the pathogenesis of neointimal formation associated with late vein graft failure, in-stent restenosis, and transplant arteriopathy. Viral vectors transduce SMC with low efficiency and hence, there is a need for improvement. We aimed to enhance the efficiency and selectivity of gene delivery to human SMC. Targeting ligands were identified using phage display on primary human saphenous vein SMC with linear and cyclic libraries. Two linear peptides, EYHHYNK (EYH) and GETRAPL (GET), were incorporated into the HI loop of adenovirus (Ad) fibers and the capsid protein of adeno-associated virus-2 (AAV-2). Exposure of human venous SMC to EYH-modified (but not the GET-modified) Ad vector resulted in a significant increase in transgene expression levels at short, clinically relevant exposure times. Similarly, the EYH-modified AAV vector resulted in enhanced gene transfer to human venous SMC but not endothelial cells in a time- and dose-dependent manner. The EYH-modified AAV vector also enhanced (up to 70-fold) gene delivery to primary human arterial SMC. Hence, incorporation of EYH into Ad and AAV capsids resulted in a significant and selective enhancement in transduction of SMC and has implications for improving local gene delivery to the vasculature.

摘要

血管平滑肌细胞(SMC)在与晚期静脉移植物衰竭、支架内再狭窄和移植血管病相关的新生内膜形成的发病机制中不可或缺。病毒载体转导SMC的效率较低,因此需要改进。我们旨在提高基因传递至人SMC的效率和选择性。使用线性和环状文库在原代人隐静脉SMC上进行噬菌体展示来鉴定靶向配体。将两种线性肽,EYHHYNK(EYH)和GETRAPL(GET),分别掺入腺病毒(Ad)纤维的HI环和腺相关病毒2(AAV-2)的衣壳蛋白中。将人静脉SMC暴露于EYH修饰(而非GET修饰)的Ad载体,在短时间、临床相关暴露时间下,转基因表达水平显著增加。同样,EYH修饰的AAV载体以时间和剂量依赖性方式增强了向人静脉SMC而非内皮细胞的基因转移。EYH修饰的AAV载体还将向原代人动脉SMC的基因传递增强了(高达70倍)。因此,将EYH掺入Ad和AAV衣壳中可显著且选择性地增强SMC的转导,对改善向脉管系统的局部基因传递具有重要意义。

相似文献

1
Development of efficient viral vectors selective for vascular smooth muscle cells.针对血管平滑肌细胞的高效病毒载体的研发。
Mol Ther. 2004 Feb;9(2):198-208. doi: 10.1016/j.ymthe.2003.11.006.
2
Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells.高效且选择性地将腺相关病毒2介导的基因转移至人血管内皮细胞。
Mol Ther. 2001 Sep;4(3):174-81. doi: 10.1006/mthe.2001.0424.
3
Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation.腺相关病毒(AAV)-7和-8对血管内皮细胞的转导效率较低,且对蛋白酶体降解敏感。
Gene Ther. 2005 Oct;12(20):1534-8. doi: 10.1038/sj.gt.3302564.
4
Gene delivery to in situ veins: differential effects of adenovirus and adeno-associated viral vectors.基因导入原位静脉:腺病毒和腺相关病毒载体的不同作用
J Vasc Surg. 2000 Jun;31(6):1149-59.
5
Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors.利用腺相关病毒和腺病毒载体将基因导入兔动脉。
J Gene Med. 2004 May;6(5):545-54. doi: 10.1002/jgm.535.
6
Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob.在纤维钮的HI环和C末端均含有异源肽的纤维修饰腺病毒载体的构建
J Gene Med. 2003 Apr;5(4):267-76. doi: 10.1002/jgm.348.
7
Targeting of high-capacity adenoviral vectors.高容量腺病毒载体的靶向性
Hum Gene Ther. 2001 Sep 20;12(14):1757-69. doi: 10.1089/104303401750476258.
8
Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer.使用腺病毒和腺相关病毒介导的基因转移,研究豚鼠耳蜗的耳蜗功能和转基因表达。
Hum Gene Ther. 2001 May 1;12(7):773-81. doi: 10.1089/104303401750148702.
9
Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.2型腺相关病毒(AAV2)衣壳基因的插入诱变及靶向替代细胞表面受体的AAV2载体的产生。
Hum Gene Ther. 2001 Sep 20;12(14):1697-711. doi: 10.1089/104303401750476212.
10
Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy.第三代慢病毒载体可有效转导并对血管细胞进行表型修饰:对基因治疗的意义。
J Mol Cell Cardiol. 2003 Jul;35(7):739-48. doi: 10.1016/s0022-2828(03)00136-6.

引用本文的文献

1
AAV library screening identifies novel vector for efficient transduction of human aorta.腺相关病毒文库筛选鉴定出用于高效转导人主动脉的新型载体。
Gene Ther. 2025 Mar;32(2):154-162. doi: 10.1038/s41434-024-00511-8. Epub 2024 Dec 18.
2
Targeting the smooth muscle cell Keap1-Nrf2-GSDMD-pyroptosis axis by cryptotanshinone prevents abdominal aortic aneurysm formation.通过隐丹参酮靶向平滑肌细胞 Keap1-Nrf2-GSDMD-细胞焦亡轴预防腹主动脉瘤形成。
Theranostics. 2024 Oct 7;14(17):6516-6542. doi: 10.7150/thno.98400. eCollection 2024.
3
An antisense oligonucleotide efficiently suppresses splicing of an alternative exon in vascular smooth muscle in vivo.
一种反义寡核苷酸在体内有效地抑制了血管平滑肌中可变外显子的剪接。
Am J Physiol Heart Circ Physiol. 2024 Mar 1;326(3):H860-H869. doi: 10.1152/ajpheart.00745.2023. Epub 2024 Jan 26.
4
Mitochondrial Homeostasis in VSMCs as a Central Hub in Vascular Remodeling.血管平滑肌细胞中的线粒体稳态作为血管重塑的核心枢纽
Int J Mol Sci. 2023 Feb 9;24(4):3483. doi: 10.3390/ijms24043483.
5
Identification of Broadly Applicable Adeno-Associated Virus Vectors by Systematic Comparison of Commonly Used Capsid Variants .通过对常用衣壳变体的系统比较鉴定广泛适用的腺相关病毒载体。
Hum Gene Ther. 2022 Nov;33(21-22):1197-1212. doi: 10.1089/hum.2022.109. Epub 2022 Nov 2.
6
Alginate hydrogel polymers enable efficient delivery of a vascular-targeted AAV vector into aortic tissue.藻酸盐水凝胶聚合物能够将血管靶向性腺相关病毒载体有效递送至主动脉组织。
Mol Ther Methods Clin Dev. 2021 Feb 24;21:83-93. doi: 10.1016/j.omtm.2021.02.017. eCollection 2021 Jun 11.
7
Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity.溶瘤腺病毒:提高靶向性和特异性的策略
Cancers (Basel). 2020 Jun 9;12(6):1504. doi: 10.3390/cancers12061504.
8
Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors.用于靶向和提高腺相关病毒载体效力的衣壳修饰
Mol Ther Methods Clin Dev. 2019 Jan 26;12:248-265. doi: 10.1016/j.omtm.2019.01.008. eCollection 2019 Mar 15.
9
A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases.一种具有治疗神经血管和神经系统疾病潜力的脑微血管内皮细胞特异性病毒载体。
EMBO Mol Med. 2016 Jun 1;8(6):609-25. doi: 10.15252/emmm.201506078. Print 2016 Jun.
10
Pulmonary Targeting of Adeno-associated Viral Vectors by Next-generation Sequencing-guided Screening of Random Capsid Displayed Peptide Libraries.通过下一代测序引导筛选随机衣壳展示肽库实现腺相关病毒载体的肺部靶向
Mol Ther. 2016 Jun;24(6):1050-1061. doi: 10.1038/mt.2016.62. Epub 2016 Mar 28.